1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Normal-Tension Glaucoma Global Clinical Trials Review, H2, 2015

Normal-Tension Glaucoma Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Normal-Tension Glaucoma Global Clinical Trials Review, H2, 2015" provides an overview of Normal-Tension Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Normal-Tension Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Normal-Tension Glaucoma Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Normal-Tension Glaucoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Clinical Trials by G7 Countries: Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials 15
Clinical Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Normal-Tension Glaucoma Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Pfizer Inc. 24
Clinical Trial Overview of Pfizer Inc. 24
Santen Pharmaceutical Co., Ltd. 25
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 25
Nitten Pharmaceutical Co., Ltd. 26
Clinical Trial Overview of Nitten Pharmaceutical Co., Ltd. 26
Merck and Co., Inc. 27
Clinical Trial Overview of Merck and Co., Inc. 27
Kowa Company, Ltd. 28
Clinical Trial Overview of Kowa Company, Ltd. 28
Kaken Pharmaceutical Co., Ltd. 29
Clinical Trial Overview of Kaken Pharmaceutical Co., Ltd. 29
Clinical Trial Overview of Top Institutes / Government 30
MIzoguchi Eye Clinic 30
Clinical Trial Overview of MIzoguchi Eye Clinic 30
Chinese University of Hong Kong 31
Clinical Trial Overview of Chinese University of Hong Kong 31
Kanazawa University Hospital 32
Clinical Trial Overview of Kanazawa University Hospital 32
Seoul National University Hospital 33
Clinical Trial Overview of Seoul National University Hospital 33
The Catholic University of Korea 34
Clinical Trial Overview of The Catholic University of Korea 34
Tohoku University 35
Clinical Trial Overview of Tohoku University 35
University of Erlangen-Nurnberg 36
Clinical Trial Overview of University of Erlangen-Nurnberg 36
Five Key Clinical Profiles 37
Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Disclaimer 56
Source 57

List of Tables
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Normal-Tension Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Normal-Tension Glaucoma Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 12
Normal-Tension Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Normal-Tension Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 15
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Normal-Tension Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 20
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 24
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 25
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Nitten Pharmaceutical Co., Ltd., 2015* 26
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 27
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015* 28
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaken Pharmaceutical Co., Ltd., 2015* 29
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MIzoguchi Eye Clinic, 2015* 30
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 31
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa University Hospital, 2015* 32
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 33
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Catholic University of Korea, 2015* 34
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2015* 35
Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Erlangen-Nurnberg, 2015* 36

List of Figures
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Normal-Tension Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 12
Normal-Tension Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Normal-Tension Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 15
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Normal-Tension Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 20
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
GlobalData Methodology 55

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.